Investigations for Suspected Head and Neck Squamous Cell Carcinoma of Unknown Primary (HNSCCUP): A National Cohort Study
Authors:
- John C. HardmanJHJohn C. Hardman
- James ConstableJCJames Constable
- Andrew WilliamsonAWAndrew Williamson
- Sian DobbsSDSian Dobbs
- Christopher HoganCHChristopher Hogan
- Kate HulseKHKate Hulse
- Shivun KhoslaSKShivun Khosla
- Kristijonas MilinisKMKristijonas Milinis
- Ben Tudor‐GreenBTBen Tudor‐Green
- Vinidh PaleriVPVinidh Paleri
- INTEGRATE (The UK ENT Trainee Research Network)ININTEGRATE (The UK ENT Trainee Research Network)
- 8 January 2025
- journal article
- research article
- Published by Wiley in Clinical Otolaryngology
- Vol. 50 (3) , 462-473
Abstract
Objectives: Head and neck squamous cell carcinoma from unknown primary (HNSCCUP) is a rare and challenging condition. This study aimed to investigate the diagnostic pathways of suspected HNSCCUP patients in the United Kingdom.Methods: A retrospective observational cohort study was conducted, over 5 years from January 2015, in UK Head and Neck centres of consecutive adults undergoing 18F‐Fluorodeoxyglucose‐PET‐CT (PET‐CT) within 3 months of diagnosis with metastatic cervical squamous cell carcinoma. Patients with no primary site on examination and no previous head and neck cancer were eligible.Results: Data for 965 patients were received from 57 centres; 68.5% were HPV‐related disease. Three investigation cycles were observed: ultrasound with biopsy, cross‐sectional imaging (MRI and/or CT) and PET‐CT, at median times of 17, 29.5 and 46 days from referral. No primary was identified on PET‐CT in 49.8% (n = 478/960). Diagnostic tonsillectomy was performed in 58.2% (n = 278/478) and tongue base mucosectomy (TBM) in 21.7% (n = 104/479). Ipsilateral tonsillectomy carried the highest diagnostic yield (18.7%, n = 52/278), followed by TBM (15.4%, n = 16/104). Contralateral tonsillectomy, performed in 49.0% (n = 234/478), carried the lowest yield (0.9%, n = 2/234). PET‐CT with concurrent MRI was associated with higher primary site detection than PET‐CT with concurrent CT (p = 0.003). A minority of patients undergoing treatment with curative intent received first‐definitive‐treatment within 62 days of referral (15.2%, n = 77/505, median 92 days, IQR: 71–117).Conclusions: Most patients experienced a protracted diagnostic pathway and waited over 3 months for definitive treatment. Earlier PET‐CT with concurrent MRI may expedite diagnosis. TBM appears more productive than contralateral tonsillectomy for primary site detection.Keywords
This publication has 21 references indexed in Scilit:
- UK Head and Neck Cancer Multidisciplinary Guidelines – lay summary for non-cliniciansThe Journal of Laryngology & Otology, 2024
- Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort studyClinical Otolaryngology, 2024
- Second Primary Tumors in Patients Presenting With Unilateral HPV‐Associated Tonsillar Squamous Cell CarcinomaThe Laryngoscope, 2021
- Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neckOral Oncology, 2019
- Use of Diffusion-Weighted Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell CarcinomaClinical Oncology, 2018
- PET-CT in the UK: current status and future directionsClinical Radiology, 2016
- Changes in Unknown Primary Squamous Cell Carcinoma of the Head and Neck at Initial Presentation in the Era of Human PapillomavirusJAMA Otolaryngology–Head & Neck Surgery, 2016
- Contemporary management of lymph node metastases from an unknown primary to the neck: II. A review of therapeutic optionsHead & Neck, 2011
- Metastatic Carcinoma of the Neck of Unknown Primary Origin: Evolution and Efficacy of the Modern WorkupJAMA Otolaryngology–Head & Neck Surgery, 2009
- Toxicity and response criteria of the Eastern Cooperative Oncology GroupAmerican Journal of Clinical Oncology, 1982